Custom Search

Prochlorperazine News

Alexza initiates AZ-001 phase IIb trial in patients with migraine headaches

Alexza Pharmaceuticals, Inc., (ALXA) announced that it has initiated a phase IIb clinical trial with AZ-001 (Staccato prochlorperazine) in patients with migraine headaches. AZ-001 is an inhalation product candidate being...

Alexza Pharmaceuticals, Inc. (ALXA) To Present AZ-001 Phase IIa Clinical Data At The American Headache Society Meeting

Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA - News) announced today that it will present at the 48th annual American Headache Society meeting the results of a Phase IIa clinical trial of Staccato(TM) Prochlorperazine (AZ-001) for...

New Study Shows BDSI's Emezine(R) Demonstrates More Efficient Absorption Versus Swallowed Form of Prochlorperazine

BioDelivery Sciences International, Inc. (NASDAQ:BDSI , BDSIW ) announced today the publication of a pharmacokinetic (PK) study regarding Emezine®, its investigational buccal tablet formulation of prochlorperazine maleate for the...

Delayed Nausea After Chemotherapy Poses Treatment Challenge

Neither prochlorperazine nor first-generation 5-HT-receptor antagonists offer sufficient control of delayed chemotherapy-induced nausea, according to a study published in The Lancet Oncology.

Marinol® Effective for Chemotherapy-Induced Nausea and Vomiting

A combination of Marinol® and prochlorperazine is an effective antiemetic regimen for treatment of chemotherapy-induced nausea and vomiting, according to results from a study reported in the Journal of Pain and Symptom Management.

Use of this site is subject to the following terms of use